MAD2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: In particular, TTK and MAD2L1 might increase cell proliferation in CML CD34+/lin- cells at diagnosis, and some researchers demonstrated that they were over expressed in CML leukemic stem cells compared to the same cell counterpart from normal subjects [15].